ClinicalTrials.gov
ClinicalTrials.gov Menu

Abciximab for Prevention of Stroke Recurrence Before Endarterectomy in Symptomatic Carotid Stenosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00126139
Recruitment Status : Terminated (Higher hemorrhage rates of Abciximab in ABESST II trial)
First Posted : August 2, 2005
Last Update Posted : May 3, 2007
Sponsor:
Collaborators:
Schweizerische Herzstiftung
Eli Lilly and Company
Information provided by:
University of Zurich

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : No date given
  Actual Study Completion Date : May 2005